发明名称 |
DRY POWDER FORMULATIONS FOR INHALATION |
摘要 |
A respirable dry powder including acetylsalicylic acid in particles having a mass median aerodynamic diameter (MMAD) within a range of about 0.5 μm to about 10 μm. The respirable dry powder may contain a pharmaceutically acceptable excipient, such as a phospholipid, in an amount ranging from about 0.1% (w/w) to about 10% (w/w) of the particles. |
申请公布号 |
US2016022705(A1) |
申请公布日期 |
2016.01.28 |
申请号 |
US201514628148 |
申请日期 |
2015.02.20 |
申请人 |
OtiTopic Inc. |
发明人 |
YADIDI Kambiz |
分类号 |
A61K31/616;A61K31/4365;A61K9/00;A61K9/16 |
主分类号 |
A61K31/616 |
代理机构 |
|
代理人 |
|
主权项 |
1. A respirable dry powder comprising respirable dry particles that comprise acetylsalicylic acid, or a pharmaceutically acceptable salt thereof; wherein said dry powder comprises substantially dry particles having a mass median aerodynamic diameter (MMAD) within a range of about 0.5 μm to about 10 μm, wherein the dry powder further comprises one or more phospholipids in an amount ranging from about 0.1% (w/w) to about 10% (w/w) of the dry particles. |
地址 |
Los Angeles CA US |